UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?

BioMed research international, 2018-01, Vol.2018 (2018), p.1-15

2018

Volltextzugriff (PDF)

A method for patient-specific evaluation of vertebral cancellous bone strength: In vitro validation

Clinical biomechanics (Bristol), 2007-03, Vol.22 (3), p.282-291

2007

Volltextzugriff (PDF)

Doping and temperature dependence of the superconducting energy gap in the electron-doped cuprate Pr2−xCexCuO4−δ

Physica. C, Superconductivity, 2010-12, Vol.470 (SUP1), p.S181-S182

2010

Volltextzugriff (PDF)

Energy dependence of the electron-boson coupling strength in the electron-doped cuprate superconductor Pr1.85Ce0.15CuO4−δ

Physical review. B, 2017-02, Vol.95 (8)

2017

Volltextzugriff (PDF)

Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis

Drug safety, 2024-01, Vol.47 (1), p.39-57

2024

Volltextzugriff (PDF)

The Politics of Veteran Benefits in the Twentieth Century: A Comparative History

Martin Crotty, Neil J. Diamant, Mark Edele

1, 2020

Volltextzugriff (PDF)

Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials

Journal of the American Academy of Dermatology, 2023-08, Vol.89 (2), p.274-282

2023

Volltextzugriff (PDF)

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

The New England journal of medicine, 2021-03, Vol.384 (12), p.1101-1112

2021

Volltextzugriff (PDF)

How to select the elastic modulus for cancellous bone in patient-specific continuum models of the spine

Medical & biological engineering & computing, 2005-07, Vol.43 (4), p.465-472

2005

Volltextzugriff (PDF)

Prediction of the apparent elastic modulus and strength of vertebral cancellous bone based on patient-specific apparent morphology

Journal of biomechanics, 2006, Vol.39, p.S5-S5

2006

Volltextzugriff (PDF)

Improvements in itch and sleep following treatment with baricitinib in combination with topical corticosteroids are associated with better quality of life and productivity in adult patients with moderate-to-severe atopic dermatitis: a post hoc analysis from BREEZE-AD7

EJD. European journal of dermatology, 2022-04, Vol.32 (2), p.237-243

2022

Volltextzugriff (PDF)

A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting

EJD. European journal of dermatology, 2023-01, Vol.33 (1), p.25-33

2023

Volltextzugriff (PDF)

Minimum Delay Multipath Routing Based on TDMA for Underwater Acoustic Sensor Network

International journal of distributed sensor networks, 2016-01, Vol.2016 (2), p.1394340

2016

Volltextzugriff (PDF)

Optimization of LDPC Codes over the Underwater Acoustic Channel

International journal of distributed sensor networks, 2016-01, Vol.2016 (2), p.8906985

2016

Volltextzugriff (PDF)

Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline

American journal of respiratory and critical care medicine, 2021-11, Vol.204 (10), p.e97-e109

2021

Volltextzugriff (PDF)

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Journal of Crohn's & colitis, 2016-03, Vol.10 (3), p.239-254

2016

Volltextzugriff (PDF)

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

The New England journal of medicine, 2017-03, Vol.376 (9), p.826-835

2017

Volltextzugriff (PDF)

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

The New England journal of medicine, 2016-07, Vol.375 (4), p.345-356

2016

Volltextzugriff (PDF)

In memoriam, Professor Bo Lundbäck (1948–2022), Respiratory Medicine Associate Editor

Respiratory medicine, 2023-04, Vol.209, p.107153, Article 107153

2023

Volltextzugriff (PDF)

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

The Lancet (British edition), 2023-09, Vol.402 (10404), p.798-808

2023

Volltextzugriff (PDF)

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

The Lancet (British edition), 2017-06, Vol.389 (10086), p.2317-2327

2017

Volltextzugriff (PDF)

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

The Lancet (British edition), 2015-08, Vol.386 (9993), p.552-561

2015

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

The Lancet (British edition), 2013-08, Vol.382 (9894), p.780-789

2013

Volltextzugriff (PDF)

Childhood asthma outcomes during the COVID‐19 pandemic: Findings from the PeARL multi‐national cohort

Allergy (Copenhagen), 2021-06, Vol.76 (6), p.1765-1775

2021

Volltextzugriff (PDF)

Safety and efficacy of unpreserved timolol 0.1% gel in patients controlled by preserved latanoprost with signs of ocular intolerance

Journal francais d'ophtalmologie, 2013-04, Vol.36 (4), p.316-323

2013

Volltextzugriff (PDF)

1 – 25 von 4.170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.177)
Mit Volltextzugriff
(3.091)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.864)
Life Sciences & Biomedicine
(1.495)
Humans
(1.246)
Female
(679)
Male
(637)
Biological And Medical Sciences
(498)
Adult
(467)
Middle Aged
(412)
Animals
(374)
Medical Sciences
(348)
Physical Sciences
(251)
Technology
(238)
Aged
(222)
Fundamental And Applied Biological Sciences. Psychology
(187)
Adolescent
(164)
Endocrinology & Metabolism
(164)
Treatment Outcome
(156)
Rats
(154)
Diabetes
(147)
Dermatology
(139)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Back Stage
(95)
Gastroenterology
(70)
Journal Of The American Academy Of Dermatology
(70)
Diabetes Care
(55)
American Journal Of Physiology: Gastrointestinal And Liver Physiology
(51)
Acta Oto-Laryngologica
(49)
Children & Libraries
(46)
Allergy
(44)
Skin
(43)
The Journal Of Politics
(40)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?

A method for patient-specific evaluation of vertebral cancellous bone strength: In vitro validation

Doping and temperature dependence of the superconducting energy gap in the electron-doped cuprate Pr2−xCexCuO4−δ

Energy dependence of the electron-boson coupling strength in the electron-doped cuprate superconductor Pr1.85Ce0.15CuO4−δ

Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis

The Politics of Veteran Benefits in the Twentieth Century: A Comparative History

Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

How to select the elastic modulus for cancellous bone in patient-specific continuum models of the spine

Prediction of the apparent elastic modulus and strength of vertebral cancellous bone based on patient-specific apparent morphology

Improvements in itch and sleep following treatment with baricitinib in combination with topical corticosteroids are associated with better quality of life and productivity in adult patients with moderate-to-severe atopic dermatitis: a post hoc analysis from BREEZE-AD7

A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting

Minimum Delay Multipath Routing Based on TDMA for Underwater Acoustic Sensor Network

Optimization of LDPC Codes over the Underwater Acoustic Channel

Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

In memoriam, Professor Bo Lundbäck (1948–2022), Respiratory Medicine Associate Editor

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

Childhood asthma outcomes during the COVID‐19 pandemic: Findings from the PeARL multi‐national cohort

Safety and efficacy of unpreserved timolol 0.1% gel in patients controlled by preserved latanoprost with signs of ocular intolerance

Suchergebnisse filtern